It has been suggested that FSH stimulates ovarian cancer cell proliferation via FSHR isoform 3, which is not coupled with G-proteins and not associated with cAMP production, but activates the Erk pathway in a Ca2+-dependent manner (130, 131). This evidence concerns the gene BRD2 and ovarian cancer.